Immunocore Ownership 2024 | Who Owns Immunocore Now?
Institutional Ownership
12.60%
Insider Ownership
5.29%
Retail Ownership
82.11%
Institutional Holders
48.00
Immunocore Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| WELLINGTON MANAGEMENT GROUP LLP | 12.79% | 0.04% | 6,380,451 | 633,181 | 11.02% | 216,233,483 | Jun 30, 2024 |
| RTW INVESTMENTS, LP | 9.76% | 2.56% | 4,869,798 | -1,149,843 | -19.10% | 165,037,454 | Jun 30, 2024 |
| FMR LLC | 9.65% | 0.01% | 4,812,604 | 500,460 | 11.61% | 163,099,159 | Jun 30, 2024 |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 6.00% | 0.06% | 2,992,273 | 2,258,662 | 307.88% | 101,409,000 | Jun 30, 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 5.68% | 0.01% | 2,832,669 | 395,085 | 16.21% | 96,000,000 | Jun 30, 2024 |
| PRIMECAP MANAGEMENT CO/CA/ | 3.91% | 0.05% | 1,951,070 | 1,901,570 | 3841.56% | 66,121,762 | Jun 30, 2024 |
| BAKER BROS. ADVISORS LP | 3.04% | 0.66% | 1,515,318 | - | - | 51,354,127 | Jun 30, 2024 |
| GENERAL ATLANTIC, L.P. | 2.53% | 1.34% | 1,261,684 | -245,000 | -16.26% | 42,758,471 | Jun 30, 2024 |
| BELLEVUE GROUP AG | 2.31% | 0.64% | 1,154,654 | 182,400 | 18.76% | 39,131,224 | Jun 30, 2024 |
| ARMISTICE CAPITAL, LLC | 1.96% | 0.42% | 976,000 | 812,000 | 495.12% | 33,076,640 | Jun 30, 2024 |
| FIERA CAPITAL CORP | 1.76% | 0.09% | 875,593 | 9,181 | 1.06% | 29,673,847 | Jun 30, 2024 |
| BLACKROCK INC. | 1.75% | 0.00% | 871,793 | 4,436 | 0.51% | 29,545,065 | Jun 30, 2024 |
| MORGAN STANLEY | 1.74% | 0.00% | 868,864 | 67,590 | 8.44% | 29,445,835 | Jun 30, 2024 |
| BRAIDWELL LP | 1.60% | 0.85% | 797,268 | 797,268 | 100.00% | 27,019,413 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 1.30% | 0.04% | 646,920 | 82,120 | 14.54% | 21,924,119 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 1.20% | 0.01% | 600,954 | 333,167 | 124.41% | 20,366,331 | Jun 30, 2024 |
| BILL & MELINDA GATES FOUNDATION | 1.16% | 32.71% | 576,923 | - | - | 19,551,920 | Jun 30, 2024 |
| POLAR CAPITAL HOLDINGS PLC | 1.01% | 0.10% | 502,570 | 1,270 | 0.25% | 17,032,097 | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | 0.88% | 0.03% | 439,453 | 303,804 | 223.96% | 14,893,062 | Jun 30, 2024 |
| PRINCIPAL FINANCIAL GROUP INC | 0.88% | 0.01% | 437,112 | -80,092 | -15.49% | 14,813,778,000 | Jun 30, 2024 |
Immunocore's largest institutional shareholder is WELLINGTON MANAGEMENT GROUP LLP, holding 12.79% of the company's total share outstanding, currently valued at $216.23M. The top 10 institutional shareholders own together 57.63% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BILL & MELINDA GATES FOUNDATION | 1.16% | 32.71% | 576,923 | - | - | 19,551,920 | Jun 30, 2024 |
| STEMPOINT CAPITAL LP | 0.68% | 3.38% | 339,351 | 339,351 | 100.00% | 11,500,605 | Jun 30, 2024 |
| RTW INVESTMENTS, LP | 9.76% | 2.56% | 4,869,798 | -1,149,843 | -19.10% | 165,037,454 | Jun 30, 2024 |
| ESCHLER ASSET MANAGEMENT LLP | 0.08% | 2.04% | 40,000 | - | - | 2,600,000 | Jun 30, 2024 |
| CANTOR FITZGERALD, L. P. | 0.51% | 1.70% | 254,027 | 254,027 | 100.00% | 8,608,975 | Jun 30, 2024 |
| FIRST TURN MANAGEMENT, LLC | 0.58% | 1.60% | 291,086 | -103,588 | -26.25% | 9,864,905 | Jun 30, 2024 |
| TANG CAPITAL MANAGEMENT LLC | 0.81% | 1.40% | 405,600 | - | - | 13,745,784 | Jun 30, 2024 |
| GENERAL ATLANTIC, L.P. | 2.53% | 1.34% | 1,261,684 | -245,000 | -16.26% | 42,758,471 | Jun 30, 2024 |
| BRAIDWELL LP | 1.60% | 0.85% | 797,268 | 797,268 | 100.00% | 27,019,413 | Jun 30, 2024 |
| BAKER BROS. ADVISORS LP | 3.04% | 0.66% | 1,515,318 | - | - | 51,354,127 | Jun 30, 2024 |
| BELLEVUE GROUP AG | 2.31% | 0.64% | 1,154,654 | 182,400 | 18.76% | 39,131,224 | Jun 30, 2024 |
| HEALTHINVEST PARTNERS AB | 0.05% | 0.49% | 23,778 | -17,121 | -41.86% | 805,836 | Jun 30, 2024 |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 0.84% | 0.43% | 419,030 | -1,948,786 | -82.30% | 14,200,927 | Jun 30, 2024 |
| ARMISTICE CAPITAL, LLC | 1.96% | 0.42% | 976,000 | 812,000 | 495.12% | 33,076,640 | Jun 30, 2024 |
| PIER CAPITAL, LLC | 0.16% | 0.41% | 81,306 | -6,748 | -7.66% | 2,755,460 | Jun 30, 2024 |
| AVIDITY PARTNERS MANAGEMENT LP | 0.40% | 0.29% | 200,000 | -86,400 | -30.17% | 6,778,000 | Jun 30, 2024 |
| EAGLE HEALTH INVESTMENTS LP | 0.09% | 0.28% | 46,300 | - | - | 1,569,107 | Jun 30, 2024 |
| NAN FUNG GROUP HOLDINGS LTD | 0.01% | 0.24% | 6,750 | - | - | 228,758 | Jun 30, 2024 |
| RHENMAN & PARTNERS ASSET MANAGEMENT AB | 0.12% | 0.19% | 58,278 | -21,500 | -26.95% | 1,975,041 | Jun 30, 2024 |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 0.22% | 0.17% | 108,762 | 108,762 | 100.00% | 3,685,944 | Jun 30, 2024 |
The largest Immunocore shareholder by % of total assets is BILL & MELINDA GATES FOUNDATION. The company owns 576.92K shares of Immunocore (IMCR), representing 32.71% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 6.00% | 0.06% | 2,992,273 | 2,258,662 | 307.88% | 101,409,000 | Jun 30, 2024 |
| PRIMECAP MANAGEMENT CO/CA/ | 3.91% | 0.05% | 1,951,070 | 1,901,570 | 3841.56% | 66,121,762 | Jun 30, 2024 |
| ARMISTICE CAPITAL, LLC | 1.96% | 0.42% | 976,000 | 812,000 | 495.12% | 33,076,640 | Jun 30, 2024 |
| BRAIDWELL LP | 1.60% | 0.85% | 797,268 | 797,268 | 100.00% | 27,019,413 | Jun 30, 2024 |
| WELLINGTON MANAGEMENT GROUP LLP | 12.79% | 0.04% | 6,380,451 | 633,181 | 11.02% | 216,233,483 | Jun 30, 2024 |
| FMR LLC | 9.65% | 0.01% | 4,812,604 | 500,460 | 11.61% | 163,099,159 | Jun 30, 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 5.68% | 0.01% | 2,832,669 | 395,085 | 16.21% | 96,000,000 | Jun 30, 2024 |
| STEMPOINT CAPITAL LP | 0.68% | 3.38% | 339,351 | 339,351 | 100.00% | 11,500,605 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 1.20% | 0.01% | 600,954 | 333,167 | 124.41% | 20,366,331 | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | 0.88% | 0.03% | 439,453 | 303,804 | 223.96% | 14,893,062 | Jun 30, 2024 |
| LOOMIS SAYLES & CO L P | 0.61% | 0.01% | 301,815 | 282,817 | 1488.67% | 10,228,000 | Jun 30, 2024 |
| CANTOR FITZGERALD, L. P. | 0.51% | 1.70% | 254,027 | 254,027 | 100.00% | 8,608,975 | Jun 30, 2024 |
| HUDSON BAY CAPITAL MANAGEMENT LP | 0.39% | 0.03% | 193,179 | 193,179 | 100.00% | 6,546,836 | Jun 30, 2024 |
| BELLEVUE GROUP AG | 2.31% | 0.64% | 1,154,654 | 182,400 | 18.76% | 39,131,224 | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | 0.50% | 0.01% | 251,819 | 159,822 | 173.73% | 8,534,146 | Jun 30, 2024 |
| SG AMERICAS SECURITIES, LLC | 0.32% | 0.03% | 160,358 | 152,207 | 1867.34% | 5,435,000 | Jun 30, 2024 |
| CANDRIAM S.C.A. | 0.63% | 0.06% | 313,423 | 124,417 | 65.83% | 10,621,410 | Jun 30, 2024 |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 0.22% | 0.17% | 108,762 | 108,762 | 100.00% | 3,685,944 | Jun 30, 2024 |
| WALLEYE CAPITAL LLC | 0.18% | 0.01% | 89,208 | 88,977 | 38518.18% | 3,023,259 | Jun 30, 2024 |
| LEGAL & GENERAL GROUP PLC | 0.24% | 0.00% | 120,517 | 84,472 | 234.35% | 4,084,321 | Jun 30, 2024 |
As of Jun 30 2024, Immunocore's largest institutional buyer is T. ROWE PRICE INVESTMENT MANAGEMENT, INC.. The company purchased 2.26M stocks of IMCR, valued at $101.41M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 0.84% | 0.43% | 419,030 | -1,948,786 | -82.30% | 14,200,927 | Jun 30, 2024 |
| PARADIGM BIOCAPITAL ADVISORS LP | - | - | - | -1,787,176 | -100.00% | - | Jun 30, 2024 |
| RTW INVESTMENTS, LP | 9.76% | 2.56% | 4,869,798 | -1,149,843 | -19.10% | 165,037,454 | Jun 30, 2024 |
| LOGOS GLOBAL MANAGEMENT LP | - | - | - | -900,000 | -100.00% | - | Jun 30, 2024 |
| PICTET ASSET MANAGEMENT HOLDING SA | - | - | - | -706,607 | -100.00% | - | Jun 30, 2024 |
| JANUS HENDERSON GROUP PLC | - | - | - | -257,080 | -100.00% | - | Jun 30, 2024 |
| GENERAL ATLANTIC, L.P. | 2.53% | 1.34% | 1,261,684 | -245,000 | -16.26% | 42,758,471 | Jun 30, 2024 |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 0.05% | 0.00% | 27,139 | -191,753 | -87.60% | 919,741 | Jun 30, 2024 |
| ARTISAN PARTNERS LIMITED PARTNERSHIP | - | - | - | -126,610 | -100.00% | - | Jun 30, 2024 |
| COWEN AND COMPANY, LLC | - | - | - | -121,092 | -100.00% | - | Jun 30, 2024 |
| D. E. SHAW & CO., INC. | 0.04% | 0.00% | 19,515 | -120,579 | -86.07% | 661,363 | Jun 30, 2024 |
| GREAT POINT PARTNERS LLC | - | - | - | -115,000 | -100.00% | - | Jun 30, 2024 |
| FIRST TURN MANAGEMENT, LLC | 0.58% | 1.60% | 291,086 | -103,588 | -26.25% | 9,864,905 | Jun 30, 2024 |
| VOYA INVESTMENT MANAGEMENT LLC | 0.04% | 0.00% | 18,550 | -97,745 | -84.05% | 628,660 | Jun 30, 2024 |
| ALLIANCEBERNSTEIN L.P. | - | - | - | -97,381 | -100.00% | - | Jun 30, 2024 |
| UBS ASSET MANAGEMENT AMERICAS INC | 0.00% | - | 1,224 | -92,893 | -98.70% | 41,481 | Jun 30, 2024 |
| ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC | - | - | - | -87,614 | -100.00% | - | Jun 30, 2024 |
| AVIDITY PARTNERS MANAGEMENT LP | 0.40% | 0.29% | 200,000 | -86,400 | -30.17% | 6,778,000 | Jun 30, 2024 |
| PRINCIPAL FINANCIAL GROUP INC | 0.88% | 0.01% | 437,112 | -80,092 | -15.49% | 14,813,778,000 | Jun 30, 2024 |
| NICHOLAS INVESTMENT PARTNERS, LP | - | - | - | -77,455 | -100.00% | - | Jun 30, 2024 |
As of Jun 30 2024, Immunocore's biggest institutional seller is ROCK SPRINGS CAPITAL MANAGEMENT LP. The company sold -1.95M shares of IMCR, valued at $14.20M.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| STEMPOINT CAPITAL LP | 0.68% | 3.38% | 339,351 | 339,351 | 100.00% | 11,500,605 | Jun 30, 2024 |
| CANTOR FITZGERALD, L. P. | 0.51% | 1.70% | 254,027 | 254,027 | 100.00% | 8,608,975 | Jun 30, 2024 |
| HUDSON BAY CAPITAL MANAGEMENT LP | 0.39% | 0.03% | 193,179 | 193,179 | 100.00% | 6,546,836 | Jun 30, 2024 |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 0.22% | 0.17% | 108,762 | 108,762 | 100.00% | 3,685,944 | Jun 30, 2024 |
| ENGINEERS GATE MANAGER LP | 0.08% | 0.03% | 38,179 | 38,179 | 100.00% | 1,293,886 | Jun 30, 2024 |
| Y-INTERCEPT (HONG KONG) LTD | 0.06% | 0.06% | 31,265 | 31,265 | 100.00% | 1,059,571 | Jun 30, 2024 |
| SCHONFELD STRATEGIC ADVISORS LLC | 0.06% | 0.01% | 30,936 | 30,936 | 100.00% | 1,048,420 | Jun 30, 2024 |
| UBS OCONNOR LLC | 0.06% | 0.01% | 30,000 | 30,000 | 100.00% | 94,500 | Jun 30, 2024 |
| WOLVERINE ASSET MANAGEMENT LLC | 0.05% | 0.01% | 26,800 | 26,800 | 100.00% | 908,252 | Jun 30, 2024 |
| TORNO CAPITAL, LLC | 0.03% | 0.02% | 15,000 | 15,000 | 100.00% | 508,350 | Jun 30, 2024 |
| SEVEN EIGHT CAPITAL, LP | 0.03% | 0.05% | 12,793 | 12,793 | 100.00% | 433,555 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.03% | 0.00% | 12,599 | 12,599 | 100.00% | 426,980 | Jun 30, 2024 |
| TORNO CAPITAL, LLC | 0.02% | 0.02% | 10,010 | 10,010 | 100.00% | 339,239 | Jun 30, 2024 |
| PENTWATER CAPITAL MANAGEMENT LP | 0.02% | 0.00% | 10,000 | 10,000 | 100.00% | 338,900 | Jun 30, 2024 |
| XTX TOPCO LTD | 0.02% | 0.03% | 8,943 | 8,943 | 100.00% | 303,078 | Jun 30, 2024 |
| PEAK6 INVESTMENTS LLC | 0.01% | 0.00% | 7,500 | 7,500 | 100.00% | 254,175 | Jun 30, 2024 |
| BALDWIN INVESTMENT MANAGEMENT, LLC | 0.01% | 0.03% | 7,305 | 7,305 | 100.00% | 247,566 | Jun 30, 2024 |
| PEAK6 INVESTMENTS LLC | 0.00% | 0.00% | 1,500 | 1,500 | 100.00% | 50,835 | Jun 30, 2024 |
| CI INVESTMENTS INC. | 0.00% | 0.00% | 1,293 | 1,293 | 100.00% | 44,000 | Jun 30, 2024 |
| CLEARSTEAD ADVISORS, LLC | 0.00% | 0.00% | 348 | 348 | 100.00% | 11,794 | Jun 30, 2024 |
| ASHTON THOMAS PRIVATE WEALTH, LLC | 0.00% | 0.00% | 168 | 168 | 100.00% | 5,694 | Jun 30, 2024 |
| EVERSOURCE WEALTH ADVISORS, LLC | 0.00% | 0.00% | 167 | 167 | 100.00% | 6,630 | Jun 30, 2024 |
| FARTHER FINANCE ADVISORS, LLC | 0.00% | 0.00% | 99 | 99 | 100.00% | 3,607 | Jun 30, 2024 |
Immunocore's largest new institutional shareholder by number of shares is STEMPOINT CAPITAL LP, purchased 339.35K shares, valued at $11.50M, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| PARADIGM BIOCAPITAL ADVISORS LP | - | - | - | -1,787,176 | -100.00% | - | Jun 30, 2024 |
| LOGOS GLOBAL MANAGEMENT LP | - | - | - | -900,000 | -100.00% | - | Jun 30, 2024 |
| PICTET ASSET MANAGEMENT HOLDING SA | - | - | - | -706,607 | -100.00% | - | Jun 30, 2024 |
| JANUS HENDERSON GROUP PLC | - | - | - | -257,080 | -100.00% | - | Jun 30, 2024 |
| ARTISAN PARTNERS LIMITED PARTNERSHIP | - | - | - | -126,610 | -100.00% | - | Jun 30, 2024 |
| COWEN AND COMPANY, LLC | - | - | - | -121,092 | -100.00% | - | Jun 30, 2024 |
| GREAT POINT PARTNERS LLC | - | - | - | -115,000 | -100.00% | - | Jun 30, 2024 |
| ALLIANCEBERNSTEIN L.P. | - | - | - | -97,381 | -100.00% | - | Jun 30, 2024 |
| ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC | - | - | - | -87,614 | -100.00% | - | Jun 30, 2024 |
| NICHOLAS INVESTMENT PARTNERS, LP | - | - | - | -77,455 | -100.00% | - | Jun 30, 2024 |
| HSBC HOLDINGS PLC | - | - | - | -65,784 | -100.00% | - | Jun 30, 2024 |
| LAURION CAPITAL MANAGEMENT LP | - | - | - | -53,332 | -100.00% | - | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | - | - | - | -46,700 | -100.00% | - | Jun 30, 2024 |
| BARCLAYS PLC | - | - | - | -43,800 | -100.00% | - | Jun 30, 2024 |
| NATIONAL BANK OF CANADA /FI/ | - | - | - | -37,400 | -100.00% | - | Jun 30, 2024 |
| HIGHVISTA STRATEGIES LLC | - | - | - | -34,762 | -100.00% | - | Jun 30, 2024 |
| ENSIGN PEAK ADVISORS, INC | - | - | - | -26,679 | -100.00% | - | Jun 30, 2024 |
| AMERIPRISE FINANCIAL INC | - | - | - | -24,866 | -100.00% | - | Jun 30, 2024 |
| L & S ADVISORS INC | - | - | - | -20,796 | -100.00% | - | Jun 30, 2024 |
| ALLIANZ ASSET MANAGEMENT GMBH | - | - | - | -15,800 | -100.00% | - | Jun 30, 2024 |
| OPPENHEIMER & CO INC | - | - | - | -14,072 | -100.00% | - | Jun 30, 2024 |
| SCHRODER INVESTMENT MANAGEMENT GROUP | - | - | - | -14,000 | -100.00% | - | Jun 30, 2024 |
| MUTUAL OF AMERICA CAPITAL MANAGEMENT LLC | - | - | - | -13,063 | -100.00% | - | Jun 30, 2024 |
| FORA CAPITAL, LLC | - | - | - | -11,957 | -100.00% | - | Jun 30, 2024 |
| JEFFERIES FINANCIAL GROUP INC. | - | - | - | -11,300 | -100.00% | - | Jun 30, 2024 |
| LEGATO CAPITAL MANAGEMENT LLC | - | - | - | -10,175 | -100.00% | - | Jun 30, 2024 |
| DALTON INVESTMENTS LLC | - | - | - | -10,000 | -100.00% | - | Jun 30, 2024 |
| FRED ALGER MANAGEMENT, LLC | - | - | - | -9,479 | -100.00% | - | Jun 30, 2024 |
| CAPTION MANAGEMENT, LLC | - | - | - | -9,212 | -100.00% | - | Jun 30, 2024 |
| CAMPBELL & CO INVESTMENT ADVISER LLC | - | - | - | -7,322 | -100.00% | - | Jun 30, 2024 |
| SEI INVESTMENTS CO | - | - | - | -5,807 | -100.00% | - | Jun 30, 2024 |
| CONNECTIVE PORTFOLIO MANAGEMENT, LLC | - | - | - | -5,000 | -100.00% | - | Jun 30, 2024 |
| JGP GLOBAL GESTAO DE RECURSOS LTDA. | - | - | - | -4,253 | -100.00% | - | Jun 30, 2024 |
| BELVEDERE TRADING LLC | - | - | - | -4,200 | -100.00% | - | Jun 30, 2024 |
| WALLEYE TRADING LLC | - | - | - | -4,000 | -100.00% | - | Jun 30, 2024 |
| QUANTBOT TECHNOLOGIES LP | - | - | - | -1,500 | -100.00% | - | Jun 30, 2024 |
| NEWEDGE ADVISORS, LLC | - | - | - | -90 | -100.00% | - | Jun 30, 2024 |
| GENEOS WEALTH MANAGEMENT INC. | - | - | - | -11 | -100.00% | - | Jun 30, 2024 |
Immunocore's largest sold out institutional shareholder by shares sold is PARADIGM BIOCAPITAL ADVISORS LP, sold -1.79M shares, valued at -, as of undefined.
Immunocore Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| T. Rowe Price Health Sciences Fund, Inc. | 4.64% | 15,469,000 | 15,469,000 | - | Mar 31, 2024 |
| Fiera Capital Series Trust | 0.68% | 13,590 | 13,590 | - | Jun 30, 2023 |
| T. Rowe Price Equity Series, Inc. | 0.45% | 739,000 | 739,000 | - | Mar 31, 2024 |
| T. Rowe Price Health Sciences Fund, Inc. | 0.36% | 1,214,407 | -731,067 | -37.58% | Mar 31, 2024 |
| Virtus Strategy Trust | 0.31% | 6,600,000 | 6,600,000 | - | Mar 28, 2024 |
| Virtus Equity & Convertible Income Fund | 0.31% | 605,000 | 605,000 | - | Jan 31, 2024 |
| Virtus Dividend, Interest & Premium Strategy Fund | 0.30% | 715,000 | 715,000 | - | Jan 31, 2024 |
| Virtus Diversified Income & Convertible Fund | 0.26% | 525,000 | 525,000 | - | Jan 31, 2024 |
| FIDELITY FINANCIAL TRUST | 0.21% | 3,806,000 | 3,806,000 | - | Feb 29, 2024 |
| Virtus Convertible & Income Fund II | 0.17% | 650,000 | 650,000 | - | Jan 31, 2024 |
| Virtus Convertible & Income Fund | 0.17% | 825,000 | 825,000 | - | Jan 31, 2024 |
| T. Rowe Price All-Cap Opportunities Fund, Inc. | 0.17% | 306,380 | 306,380 | - | Mar 31, 2024 |
| Tema ETF Trust | 0.09% | 3,886 | 58 | 1.52% | Feb 29, 2024 |
| T. Rowe Price New Horizons Fund, Inc. | 0.08% | 409,100 | 35,500 | 9.50% | Mar 31, 2024 |
| BlackRock Health Sciences Trust | 0.05% | 12,497 | - | - | Mar 31, 2024 |
| T. Rowe Price Small-Cap Stock Fund, Inc. | 0.05% | 172,700 | -300 | -0.17% | Mar 31, 2024 |
| ALLSPRING VARIABLE TRUST | 0.05% | 28,532 | 1,800 | 6.73% | Mar 31, 2024 |
| T. Rowe Price Equity Series, Inc. | 0.04% | 69,222 | -23,310 | -25.19% | Mar 31, 2024 |
| FIDELITY MT VERNON STREET TRUST | 0.04% | 1,125,223 | 839,252 | 293.47% | Feb 29, 2024 |
| T. Rowe Price Small-Cap Value Fund, Inc. | 0.03% | 236,300 | 236,300 | - | Mar 31, 2024 |
| FIDELITY ADVISOR SERIES VII | 0.03% | 233,462 | 139,702 | 149.00% | Jan 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND IV | 0.02% | 61,756 | 61,756 | - | Mar 31, 2024 |
| BlackRock Health Sciences Trust II | 0.02% | 59,868 | - | - | Mar 31, 2024 |
| FIDELITY CAPITAL TRUST | 0.01% | 158,900 | - | - | Jan 31, 2024 |
| VICTORY VARIABLE INSURANCE FUNDS | 0.01% | 5,770 | - | - | Mar 31, 2024 |
| MFS SERIES TRUST I | 0.01% | 205,435 | - | - | Feb 29, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND | 0.01% | 218,853 | 35,000 | 19.04% | Mar 31, 2024 |
| FIDELITY SELECT PORTFOLIOS | 0.01% | 599,622 | 391,904 | 188.67% | Feb 29, 2024 |
| T. Rowe Price Equity Funds, Inc. | 0.01% | 80,300 | - | - | Mar 31, 2024 |
| Federated Hermes Equity Funds | 0.00% | 74,361 | - | - | Jan 31, 2024 |
| ETFis Series Trust I | 0.00% | 5,104 | -161 | -3.06% | Jan 31, 2024 |
| ALPS ETF Trust | 0.00% | 36,082 | 1,510 | 4.37% | Feb 29, 2024 |
| UBS FUNDS | 0.00% | 13,501 | -1,899 | -12.33% | Mar 31, 2024 |
| Fidelity Central Investment Portfolios LLC | 0.00% | 140,000 | 140,000 | - | Mar 31, 2024 |
| FIDELITY SECURITIES FUND | 0.00% | 204,656 | - | - | Jan 31, 2024 |
| FIDELITY COMMONWEALTH TRUST | 0.00% | 6,587 | 93 | 1.43% | Feb 29, 2024 |
| VICTORY PORTFOLIOS | 0.00% | 63,890 | - | - | Mar 31, 2024 |
| MFS VARIABLE INSURANCE TRUST | 0.00% | 60,414 | 338 | 0.56% | Mar 31, 2024 |
| BLACKROCK LARGE CAP SERIES FUNDS, INC. | 0.00% | 74,906 | - | - | Feb 29, 2024 |
| Innovator ETFs Trust | 0.00% | 6,044 | 6,044 | - | Jan 31, 2024 |
| BNY Mellon Strategic Funds, Inc. | 0.00% | 2,836 | 1,112 | 64.50% | Feb 29, 2024 |
| ETF Managers Trust | 0.00% | 8,619 | -1,757 | -16.93% | Dec 31, 2023 |
| THRIVENT SERIES FUND INC | 0.00% | 120,082 | 1,159 | 0.97% | Mar 28, 2024 |
| HARTFORD SERIES FUND INC | 0.00% | 45,413 | -64 | -0.14% | Mar 31, 2024 |
| FIDELITY ADVISOR SERIES I | 0.00% | 192,833 | -2,440 | -1.25% | Feb 29, 2024 |
| THRIVENT MUTUAL FUNDS | 0.00% | 88,919 | 820 | 0.93% | Jan 31, 2024 |
| FIRST TRUST EXCHANGE-TRADED FUND IV | 0.00% | 209,000 | 209,000 | - | Jan 31, 2024 |
| Columbia Funds Variable Series Trust II | 0.00% | 24,584 | 954 | 4.04% | Mar 31, 2024 |
| BlackRock ETF Trust | 0.00% | 643 | 23 | 3.71% | Jan 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND III | 0.00% | 5,700 | - | - | Mar 31, 2024 |
| MML SERIES INVESTMENT FUND | 0.00% | 6,297 | - | - | Dec 31, 2023 |
| T. Rowe Price Spectrum Funds II, Inc. | 0.00% | 7,092 | 7,092 | - | Feb 29, 2024 |
| ALLSPRING MASTER TRUST | 0.00% | 28,207 | -1,586 | -5.32% | Feb 29, 2024 |
| PRINCIPAL VARIABLE CONTRACTS FUNDS INC | 0.00% | 17,500 | - | - | Mar 31, 2024 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 54,759 | 8,289 | 17.84% | Jan 31, 2024 |
| MAINSTAY FUNDS TRUST | 0.00% | 81,480 | 27,420 | 50.72% | Jan 31, 2024 |
| Forethought Variable Insurance Trust | 0.00% | 1,617 | 208 | 14.76% | Mar 28, 2024 |
| Guardian Variable Products Trust | 0.00% | 5,815 | -192 | -3.20% | Mar 31, 2024 |
| Global X Funds | 0.00% | 15,181 | 3,170 | 26.39% | Jan 31, 2024 |
| T. Rowe Price Global Allocation Fund, Inc. | 0.00% | 580 | 580 | - | Jan 31, 2024 |
| MUTUAL OF AMERICA INVESTMENT CORP | 0.00% | 13,063 | -691 | -5.02% | Mar 31, 2024 |
| FIDELITY SALEM STREET TRUST | 0.00% | 1,289,000 | 1,289,000 | - | Feb 29, 2024 |
| Amplify ETF Trust | 0.00% | 6,510 | 6,510 | - | Mar 31, 2024 |
| SPDR INDEX SHARES FUNDS | 0.00% | 45,446 | 2,040 | 4.70% | Mar 31, 2024 |
| Advisors' Inner Circle Fund III | 0.00% | 12,478 | - | - | Jan 31, 2024 |
| SPDR SERIES TRUST | 0.00% | 6,180,000 | 6,180,000 | - | Mar 31, 2024 |
| North Square Investments Trust | 0.00% | 1,517 | - | - | Jan 31, 2024 |
| ETF Series Solutions | 0.00% | 3,124 | 500 | 19.05% | Feb 29, 2024 |
| JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 297,000 | 297,000 | - | Mar 31, 2024 |
| OLD WESTBURY FUNDS INC | 0.00% | 16,617 | -3,039 | -15.46% | Jan 31, 2024 |
| OHIO NATIONAL FUND INC | 0.00% | 2,525 | - | - | Mar 31, 2024 |
| Fidelity Rutland Square Trust II | 0.00% | 154,564 | 154,564 | - | Feb 29, 2024 |
| Dunham Funds | 0.00% | 7,663 | 348 | 4.76% | Jan 31, 2024 |
| MAINSTAY VP FUNDS TRUST | 0.00% | 12,418 | -1,152 | -8.49% | Mar 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 19,670 | 959 | 5.13% | Feb 29, 2024 |
| RBB FUND, INC. | 0.00% | 7,525 | 372 | 5.20% | Feb 29, 2024 |
| VALIC Co I | 0.00% | 19,971 | -2,245 | -10.11% | Feb 29, 2024 |
| Voya PARTNERS INC | 0.00% | 5,600 | - | - | Mar 31, 2024 |
| EQ ADVISORS TRUST | 0.00% | 70,000 | 70,000 | - | Mar 31, 2024 |
| ARTISAN PARTNERS FUNDS INC | 0.00% | 79,831 | - | - | Mar 31, 2024 |
| Goldman Sachs ETF Trust | 0.00% | 4,738 | -1,350 | -22.17% | Feb 29, 2024 |
| FIDELITY COVINGTON TRUST | 0.00% | 581 | - | - | Jan 31, 2024 |
| BLACKROCK FUNDS | 0.00% | 181,355 | - | - | Feb 29, 2024 |
| MASSMUTUAL SELECT FUNDS | 0.00% | 26,409 | 3,189 | 13.73% | Dec 31, 2023 |
| Franklin Alternative Strategies Funds | 0.00% | 12,000 | 12,000 | - | Feb 29, 2024 |
| MASTER INVESTMENT PORTFOLIO | 0.00% | 1,849 | 1,849 | - | Mar 31, 2024 |
| JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 44,943 | -14,531 | -24.43% | Mar 31, 2024 |
| John Hancock Funds II | 0.00% | 292,000 | 292,000 | - | Feb 29, 2024 |
| iSHARES TRUST | 0.00% | 312,475 | 57,594 | 22.60% | Mar 31, 2024 |
| MFS SERIES TRUST XV | 0.00% | 395 | -9 | -2.23% | Jan 31, 2024 |
| FIRST TRUST EXCHANGE-TRADED FUND II | 0.00% | 119 | -21 | -15.00% | Mar 31, 2024 |
| PACIFIC SELECT FUND | 0.00% | 60,978 | -3,858 | -5.95% | Mar 31, 2024 |
| HARTFORD MUTUAL FUNDS INC/CT | 0.00% | 127,626 | 4,346 | 3.53% | Jan 31, 2024 |
| JOHN HANCOCK INVESTMENT TRUST | 0.00% | 1,255 | 701 | 126.53% | Jan 31, 2024 |
| FIDELITY HASTINGS STREET TRUST | 0.00% | 95,155 | 6,066 | 6.81% | Mar 31, 2024 |
| ADVANCED SERIES TRUST | 0.00% | 44,632 | 1,739 | 4.05% | Mar 28, 2024 |
| Voya MUTUAL FUNDS | 0.00% | 2,201 | -1,576 | -41.73% | Jan 31, 2024 |
| EQ ADVISORS TRUST | 0.00% | 14,714 | -10,461 | -41.55% | Mar 31, 2024 |
| PACIFIC FUNDS SERIES TRUST | 0.00% | 3,614 | 1,378 | 61.63% | Mar 31, 2023 |
| T. Rowe Price International Funds, Inc. | 0.00% | 553,000 | 553,000 | - | Mar 31, 2024 |
Immunocore's largest mutual fund holder by % of total assets is "T. Rowe Price Health Sciences Fund, Inc.", owning 15.47M shares, compromising 4.64% of its total assets.
Immunocore Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 48 | -70.19% |
| 31 Mar, 24 | 161 | 10.27% |
| 31 Dec, 23 | 146 | 11.45% |
| 30 Sep, 23 | 131 | 4.80% |
| 30 Jun, 23 | 125 | 7.76% |
| 31 Mar, 23 | 116 | 2.65% |
| 31 Dec, 22 | 113 | 22.83% |
| 30 Sep, 22 | 92 | 27.78% |
| 30 Jun, 22 | 72 | 22.03% |
| 31 Mar, 22 | 59 | 25.53% |
| 31 Dec, 21 | 47 | 2.17% |
| 30 Sep, 21 | 46 | 6.98% |
| 30 Jun, 21 | 43 | 4.88% |
| 31 Mar, 21 | 41 | - |
As of 30 Jun 24, 48 institutions are holding Immunocore's shares, representing a decrease of -70.19% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 6,283,697 | -84.75% |
| 31 Mar, 24 | 41,196,539 | 9.88% |
| 31 Dec, 23 | 37,492,758 | 1.55% |
| 30 Sep, 23 | 36,920,468 | 4.59% |
| 30 Jun, 23 | 35,299,731 | 8.00% |
| 31 Mar, 23 | 32,686,145 | 7.92% |
| 31 Dec, 22 | 30,288,148 | 14.21% |
| 30 Sep, 22 | 26,519,589 | 26.05% |
| 30 Jun, 22 | 21,039,659 | 6.38% |
| 31 Mar, 22 | 19,778,287 | 11.68% |
| 31 Dec, 21 | 17,710,001 | 6.34% |
| 30 Sep, 21 | 16,654,136 | 15.80% |
| 30 Jun, 21 | 14,382,414 | 1.92% |
| 31 Mar, 21 | 14,110,965 | - |
Immunocore (IMCR) has 6.28M shares outstanding as of 30 Jun 24, down -84.75% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 12.60% | 177351.84% |
| 31 Mar, 24 | 0.08% | 0.00% |
| 31 Dec, 23 | 76.31% | 1.33% |
| 30 Sep, 23 | 75.82% | 1.41% |
| 30 Jun, 23 | 73.26% | 1.59% |
| 31 Mar, 23 | 67.84% | 1.55% |
| 31 Dec, 22 | 66.25% | 2.08% |
| 30 Sep, 22 | 56.43% | 2.46% |
| 30 Jun, 22 | 47.89% | 2.36% |
| 31 Mar, 22 | 45.09% | 2.77% |
| 31 Dec, 21 | 40.38% | 2.79% |
| 30 Sep, 21 | 38.03% | 3.52% |
| 30 Jun, 21 | 32.85% | 2.44% |
| 31 Mar, 21 | 36.70% | - |
As of 30 Jun 24, Immunocore is held by 12.60% institutional shareholders, representing a 177351.84% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 25 | -72.53% |
| 31 Mar, 24 | 91 | 15.19% |
| 31 Dec, 23 | 79 | 25.40% |
| 30 Sep, 23 | 63 | -19.23% |
| 30 Jun, 23 | 78 | 36.84% |
| 31 Mar, 23 | 57 | -18.57% |
| 31 Dec, 22 | 70 | 27.27% |
| 30 Sep, 22 | 55 | 96.43% |
| 30 Jun, 22 | 28 | -24.32% |
| 31 Mar, 22 | 37 | 76.19% |
| 31 Dec, 21 | 21 | -4.55% |
| 30 Sep, 21 | 22 | 4.76% |
| 30 Jun, 21 | 21 | -48.78% |
| 31 Mar, 21 | 41 | - |
25 institutional shareholders have increased their position in IMCR stock as of 30 Jun 24 compared to 91 in the previous quarter (a -72.53% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 9 | -79.07% |
| 31 Mar, 24 | 43 | 2.38% |
| 31 Dec, 23 | 42 | 5.00% |
| 30 Sep, 23 | 40 | 53.85% |
| 30 Jun, 23 | 26 | -16.13% |
| 31 Mar, 23 | 31 | 29.17% |
| 31 Dec, 22 | 24 | 26.32% |
| 30 Sep, 22 | 19 | - |
| 30 Jun, 22 | 19 | 137.50% |
| 31 Mar, 22 | 8 | -42.86% |
| 31 Dec, 21 | 14 | 75.00% |
| 30 Sep, 21 | 8 | -33.33% |
| 30 Jun, 21 | 12 | - |
| 31 Mar, 21 | - | - |
9 institutional shareholders have reduced their position in IMCR stock as of 30 Jun 24 compared to 43 in the previous quarter (a -79.07% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 48 | -70.19% | 6,283,697 | -84.75% | 12.60% | 177351.84% | 25 | -72.53% | 9 | -79.07% |
| 31 Mar, 24 | 161 | 10.27% | 41,196,539 | 9.88% | 0.08% | 0.00% | 91 | 15.19% | 43 | 2.38% |
| 31 Dec, 23 | 146 | 11.45% | 37,492,758 | 1.55% | 76.31% | 1.33% | 79 | 25.40% | 42 | 5.00% |
| 30 Sep, 23 | 131 | 4.80% | 36,920,468 | 4.59% | 75.82% | 1.41% | 63 | -19.23% | 40 | 53.85% |
| 30 Jun, 23 | 125 | 7.76% | 35,299,731 | 8.00% | 73.26% | 1.59% | 78 | 36.84% | 26 | -16.13% |
| 31 Mar, 23 | 116 | 2.65% | 32,686,145 | 7.92% | 67.84% | 1.55% | 57 | -18.57% | 31 | 29.17% |
| 31 Dec, 22 | 113 | 22.83% | 30,288,148 | 14.21% | 66.25% | 2.08% | 70 | 27.27% | 24 | 26.32% |
| 30 Sep, 22 | 92 | 27.78% | 26,519,589 | 26.05% | 56.43% | 2.46% | 55 | 96.43% | 19 | - |
| 30 Jun, 22 | 72 | 22.03% | 21,039,659 | 6.38% | 47.89% | 2.36% | 28 | -24.32% | 19 | 137.50% |
| 31 Mar, 22 | 59 | 25.53% | 19,778,287 | 11.68% | 45.09% | 2.77% | 37 | 76.19% | 8 | -42.86% |
| 31 Dec, 21 | 47 | 2.17% | 17,710,001 | 6.34% | 40.38% | 2.79% | 21 | -4.55% | 14 | 75.00% |
| 30 Sep, 21 | 46 | 6.98% | 16,654,136 | 15.80% | 38.03% | 3.52% | 22 | 4.76% | 8 | -33.33% |
| 30 Jun, 21 | 43 | 4.88% | 14,382,414 | 1.92% | 32.85% | 2.44% | 21 | -48.78% | 12 | - |
| 31 Mar, 21 | 41 | - | 14,110,965 | - | 36.70% | - | 41 | - | - | - |
Immunocore Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of Immunocore's stock was made by St Leger Tina Amber on Apr 03 2024, selling 4,375 shares at $29.87 per share (valued at $130.68K).
Immunocore Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | 7 | 2 | 350.00% |
| Q1 2024 | 9 | 51 | 17.65% |
7 total buy trades, and 2 total sell trades (buy/sell ratio of 3.50%) were made by Immunocore's insiders, as of Q2 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | - | 1 | - |
| Q1 2024 | - | 12 | - |
As of Q2 2024, Insider owners conducted 0 open market buy trades and 1 open market sell trades of Immunocore's stocks.
Immunocore Peer Ownership
| Ticker | Company |
|---|---|
| GRCL | Gracell Biotechnologies Inc. |
| DICE | DICE Therapeutics, Inc. |
| NUVL | Nuvalent, Inc. |
| KALV | KalVista Pharmaceuticals, Inc. |
| VRDN | Viridian Therapeutics, Inc. |
| LRMR | Larimar Therapeutics, Inc. |
| VTYX | Ventyx Biosciences, Inc. |
| ERAS | Erasca, Inc. |
| GLUE | Monte Rosa Therapeutics, Inc. |
| ACLX | Arcellx, Inc. |
| DSGN | Design Therapeutics, Inc. |
| PCVX | Vaxcyte, Inc. |
| LYRA | Lyra Therapeutics, Inc. |
| MIRM | Mirum Pharmaceuticals, Inc. |
IMCR Ownership FAQ
Who Owns Immunocore?
Immunocore is owned by institutional shareholders (12.60%), insiders (5.29%), and public (82.11%). The largest institutional shareholder of Immunocore is WELLINGTON MANAGEMENT GROUP LLP (12.79% of total shares) and the top mutual fund owner is T. Rowe Price Health Sciences Fund, Inc. (4.64% of total shares).
Who are the major institutional shareholders of Immunocore?
Immunocore's major institutional shareholders are WELLINGTON MANAGEMENT GROUP LLP, RTW INVESTMENTS, LP, FMR LLC, T. ROWE PRICE INVESTMENT MANAGEMENT, INC., and PRICE T ROWE ASSOCIATES INC /MD/. The top five shareholders own together 43.88% of the company's share outstanding.
How many Immunocore shareholders are there?
As of Jun 2024, there are 48 institutional shareholders of Immunocore.
What percentage of Immunocore is owned by WELLINGTON MANAGEMENT GROUP LLP?
WELLINGTON MANAGEMENT GROUP LLP owns 6.38M shares of Immunocore, representing 12.79% of the company's total shares outstanding, valued at $216.23M (as of Jun 2024).
What percentage of Immunocore is owned by RTW INVESTMENTS, LP?
As of Jun 2024, RTW INVESTMENTS, LP holds 4.87M shares of Immunocore (IMCR), compromising 9.76% of the company, valued at $165.04M.
What percentage of Immunocore is owned by FMR LLC?
FMR LLC is the third largest holder of Immunocore. The company owns 4.81M of the company's shares outstanding (worth $163.1M).